CLPT Earnings & Financial Statements
ClearPoint Neuro, Inc.
$9.50
+$0.26(+2.81%)
31
Overall
40
Value
18
Tech
36
Quality
Market Cap
$281.86M
Volume
253.18K
52W Range
$8.27 - $28.10
Target Price
$23.50
CLPT earnings and financial statements: ClearPoint Neuro, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
CLPT Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $36.97M | $31.39M | $23.95M | $20.55M | $16.30M |
| Cost of revenue | $14.28M | $12.27M | $10.34M | $7.02M | $5.18M |
| Operating income | -$24.16M | -$19.73M | -$22.45M | -$16.33M | -$13.37M |
| EBITDA | -$20.78M | -$16.43M | -$22.98M | -$15.58M | -$12.74M |
| Net income | -$25.54M | -$18.91M | -$22.09M | -$16.43M | -$14.41M |
| EPS (diluted) | $-0.90 | $-0.70 | $-0.90 | $-0.68 | $-0.69 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $97.75M | $39.19M | $42.66M | $55.49M | $65.58M |
| Total liabilities | $69.73M | $13.80M | $21.49M | $18.60M | $16.79M |
| Shareholders’ equity | $28.02M | $25.39M | $21.17M | $36.89M | $48.79M |
| Cash and equivalents | $45.90M | $20.10M | $23.10M | $27.60M | $54.10M |
| Long-term debt | $57.54M | $3.01M | $13.52M | $11.43M | $11.78M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$23.90M | -$8.95M | -$13.72M | -$16.17M | -$12.70M |
| Capital expenditure | -$522.0K | -$275.0K | -$1.05M | -$1.15M | -$168.0K |
| Free cash flow | -$24.42M | -$9.22M | -$14.77M | -$17.31M | -$12.87M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CLPT | $9.50 | +2.8% | 253.18K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |